Recurrent/Refractory CNS
1 clinical trials · Condition
◉ Watch Recurrent/Refractory CNS
| Record | Firm | Date |
|---|---|---|
| Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma (NCT01542918) | James Rubenstein | 2012-12-17 |
Track Recurrent/Refractory CNS automatically
Every clearance here is in the API, with alerts when new ones post.